Physician profile
Patrick Leary
NPI 1558362277
$1,422.07
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,067 · 2020: $128 · 2021: $129 · 2022: $31.12 · 2023: $48.72 · 2024: $18.73.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $67.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $67.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $294.96 | 2019 | |
| Pacira Therapeutics, INC. | $273.91 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $214.57 | 2019 | |
| Janssen Biotech, INC. | $146.64 | 2019 | |
| Ucb, INC. | $65.46 | 2019 | |
| Mallinckrodt Enterprises LLC | $56.63 | 2019 | |
| Smith+Nephew, INC. | $41.75 | 2023-2024 | Grafix Pl, Stravix Pl, Stravix |
| Philips North America LLC | $38.65 | 2020 | |
| Celgene Corporation | $38.05 | 2019 | |
| Abbvie INC. | $31.24 | 2019 | |
| Fidia Pharma USA INC. | $31.12 | 2022 | |
| Heraeus Medical, LLC. | $27.83 | 2019 | |
| Medtronic, INC. | $25.70 | 2023 | Venaseal |
| Gilead Sciences, INC. | $21.94 | 2021 | |
| Depuy Synthes Sales INC. | $21.16 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ibsa Pharma INC. | $19.61 | 2021 | |
| Zimmer Biomet Holdings, INC. | $16.76 | 2020 | |
| Grifols USA, LLC | $16.09 | 2020 | |
| Endo Pharmaceuticals INC. | $13.94 | 2019 | |
| Astellas Pharma US INC | $13.56 | 2021 | |
| Horizon Therapeutics Plc | $12.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Leary listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.